Select for export Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14728214.2024.2342951 PubMed 38606899 Copy citation Copy BibTeX Unknown journal 2024-04-17 Köhne S, Hillemacher T, Glahn A, Bach P. Europe PMC Published psilocybin AddictionClinical TrialReview Article Clinical Trial More
Select for export Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-024-58318-x PubMed 38632313 Copy citation Copy BibTeX Scientific Reports 2024-04-16 Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, Robert Krause, Hamideh Safi-Aghdam, Surbhi Pathania OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/psychoactives3020014 Copy citation Copy BibTeX Psychoactives 2024-04-15 Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena Aicher, Xaver Funk, Michiel van Elk OpenAlex Published psilocybin DepressionReceptor PharmacologyReview Article Review Article More
Select for export The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/15563650.2024.2346612 PubMed 38753585 Copy citation Copy BibTeX Clinical Toxicology 2024-04-01 Rachael Wilkes, Darren M. Roberts, Paul Liknaitzky, Jonathan Brett OpenAlex Published psilocybin Clinical TrialObservational StudyHealthcare Workers Clinical Trial More
Select for export Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamanetworkopen.2024.5960 PubMed 38598236 Copy citation Copy BibTeX Unknown journal 2024-03-31 Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J. Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Randomized Controlled Trial More
Select for export The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2147/dddt.s443177 PubMed 38618282 Copy citation Copy BibTeX Drug Design Development and Therapy 2024-03-31 Sarah A. Norring, Michael G. Spigarelli OpenAlex Published psilocybin PharmacologyClinical TrialObservational Study Clinical Trial More
Select for export Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241237870 PubMed 38520045 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-03-21 David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Psychedelic Renaissance: Evidence and Culture Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2024.04.4.39 Copy citation Copy BibTeX Psychiatric News 2024-03-20 Adrian Preda OpenAlex Published psilocybin DepressionPTSDNeuroplasticity Clinical Trial More
Select for export Psychedelic drugs and the law: What’s next? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1146/knowable-031424-2 Copy citation Copy BibTeX Knowable Magazine 2024-03-13 Ben Seal OpenAlex Published psilocybinpsilocin DepressionAnxietyPTSD Systematic Review More
Select for export Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/mjt.0000000000001727 PubMed 38518266 Copy citation Copy BibTeX American Journal of Therapeutics 2024-02-29 Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans OpenAlex Published psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
Select for export Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/mjt.0000000000001724 PubMed 38518269 Copy citation Copy BibTeX American Journal of Therapeutics 2024-02-29 Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans OpenAlex Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Impact of Psilocybin on Peripheral Cytokine Production Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2023.0039 PubMed 40051582 Copy citation Copy BibTeX Psychedelic Medicine 2024-02-27 Dana DiRenzo, Frederick S. Barrett, Jamie Perin, Erika Darrah, Lisa Christopher-Stine, Roland R. Griffiths OpenAlex Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00406-024-01770-7 PubMed 38411629 Copy citation Copy BibTeX Unknown journal 2024-02-26 Hashimoto K. Europe PMC Published psilocybin DepressionReceptor PharmacologyMystical Experience Clinical Trial More
Select for export Expectancy Effects in Psychedelic Trials No abstract availability was recorded for this entry. Details DOI 10.1016/j.bpsc.2024.02.004 PubMed 38387698 Copy citation Copy BibTeX Biological Psychiatry Cognitive Neuroscience and Neuroimaging 2024-02-19 Balázs Szigeti, Boris D. Heifets OpenAlex Published psilocybin Chronic PainReceptor PharmacologyClinical Trial Clinical Trial More
Select for export Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1359088 PubMed 38426002 Copy citation Copy BibTeX Unknown journal 2024-02-14 Fang S, Yang X, Zhang W. Europe PMC Published psilocybin DepressionEnd-of-Life DistressClinical Trial Randomized Controlled Trial More
Select for export Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective-a new and evolving approach Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1209419 PubMed 38362026 Copy citation Copy BibTeX Frontiers in Psychiatry 2024-01-31 Phil Wolfson, Gita Vaid OpenAlex Published psilocybin DepressionConsciousnessClinical Trial Clinical Trial More
Select for export The development of psilocybin therapy for treatment-resistant depression: an update. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjb.2023.25 PubMed 37357767 Copy citation Copy BibTeX Unknown journal 2024-01-31 Borissova A, Rucker JJ. Europe PMC Published psilocybin DepressionAnxietyAging Randomized Controlled Trial More
Select for export Psilocybin-assisted psychotherapy for cancer patients Abstract available at the source but not redistributed here. Read at source. Details DOI 10.26443/ijwpc.v11i1.390 Copy citation Copy BibTeX International Journal of Whole Person Care 2024-01-28 Houman Farzin OpenAlex Published psilocybin AnxietyConsciousnessSpirituality Clinical Trial More
Select for export Older adults in psychedelic-assisted therapy trials: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231215420 PubMed 38240068 Copy citation Copy BibTeX Unknown journal 2024-01-18 Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S Europe PMC Published psilocybin DepressionAnxietyPTSD Systematic Review More
Select for export A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2024.01.142 PubMed 38244804 Copy citation Copy BibTeX Unknown journal 2024-01-17 Wong S, Kwan ATH, Teopiz KM, Le GH, Meshkat S, Ho R Europe PMC Published psilocybin DepressionHeadache / MigraineRandomized Controlled Trial Randomized Controlled Trial More
